Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance
Explore this paper's citation graph
Summary
In DM2, subclinical myocardial injury was already detectable in preserved left ventricular ejection fraction and extracellular volume was also increased in regions with no focal fibrosis.
- Type
- article
- Published
- 2016-07-01
- Cited by
- 46
- References
- 47
- Access
- Open access
- OpenAlex
- https://openalex.org/W27363857
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1867989
Keywords
Geography
References
- CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging.
- Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
- Delayed contrast enhancement on cardiac MRI unmasks subclinical cardiomyopathy in a case of myotonic dystrophy type 2.
- Predictors of Atrio‐Ventricular Conduction Disease, Long‐Term Outcomes in Patients with Myotonic Dystrophy Types I and II
- Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases.
- Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus
- Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.
- Insulin receptor splicing alteration in myotonic dystrophy type 2.
- Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy.
- Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study
- Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study.
- Hypothyroidism unmasking proximal myotonic myopathy.
- Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.
- Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women.
- Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
- Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging
- Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland
- The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
- Sudden cardiac death in myotonic dystrophy type 2
- Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): A quantitative 31P‐MRS and MRI study
Cited by
- Targeting the Heart for Risk Assessment in Myotonic Dystrophy: An Application for Cardiac Magnetic Resonance.
- Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects
- High-sensitivity assays for troponin in patients with cardiac disease
- A Critical Appraisal of the Recent IFCC Statements on Cardiac Troponin Assays.
- Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
- Kardiomyopathien bei Muskeldystrophien
- Fatty Infiltration of the Myocardium and Arrhythmogenesis: Potential Cellular and Molecular Mechanisms
- Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery.
- Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy
- Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
- Risk Stratification of Genetic, Dilated Cardiomyopathies Associated With Neuromuscular Disorders: Role of Cardiac Imaging
- Heart involvement in patients with myotonic dystrophy type 2
- Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
- Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis
- Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction – assessment by cardiovascular magnetic resonance
- Comprehensive Cardiac Magnetic Resonance for Assessment of Cardiac Involvement in Myotonic Muscular Dystrophy Type 1 and 2 Without Known Cardiovascular Disease.
- Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality
- Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations
- The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies
- Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
Related papers
No related papers recorded.